SVB证券分析师Jonathan Chang将Calithera Biosciences(CALA)从增持下调至“与大市同步”,目标价从18美元下调至2美元。 此前该公司宣布mivavotinib和sapanisertib II期研究的初步数据预计将在2023年中期,这将超出2023年第二季度的现金流。... 网页链接
$Calithera(CALA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000597 Act: 33 Size: 1 KB 网页链接
$Calithera(CALA)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-23-070159 Act: 34 Size: 10 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070145 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070147 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070150 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070152 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070155 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070129 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070136 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070138 Act: 33 Size: 28 KB 网页链接